Tysabri

Natalizumab · Biogen Inc.
PRESCRIPTION ONLY (USA)

Tysabri ingredients

Active ingredientStrength
Natalizumab300 mg/15mL

What Tysabri is used for

The FDA lists the approved uses on the official label (below). In the EU, natalizumab is approved as Tysabri for:

Tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: Patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (DMT) (for exceptions and information about washout periods see sections 4.4 and 5.1) or Patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more Gadolinium enhancing lesions on brain MRI or a significant increase in T2 lesion load as compared to a previous recent MRI.

EU wording from the European Medicines Agency; US approved uses can differ.

Key facts

Brand
Tysabri
Generic name
Natalizumab
Made by
Biogen Inc.
Forms
Injection
Given
Intravenous
Drug class
Integrin Receptor Antagonist
FDA approval
Biologic licence (BLA) BLA125104
On the US market since
2004

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Tysabri?

Tysabri (Natalizumab) is a specialist medicine made by Biogen Inc., approved by the US FDA.

What are the ingredients of Tysabri?

Tysabri contains Natalizumab (300 mg/15mL).

Is Tysabri approved in Europe?

The same active substance is approved in the EU as Tysabri.

From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.